Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
CC transcript
Quarterly results
Auditor change
Appointed director
NeuroMetrix, Inc. (NURO) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/27/2023 8-K Quarterly results
Docs: "NeuroMetrix Reports Q2 2023 Business Highlights"
02/23/2023 8-K Quarterly results
Docs: "NeuroMetrix Reports Q4 and Full Year 2022 Financial Results"
07/21/2022 8-K Quarterly results
04/26/2022 8-K Quarterly results
Docs: "NeuroMetrix Reports Q1 2022 Financial Results"
01/27/2022 8-K Quarterly results
Docs: "NeuroMetrix Reports Q4 and Full Year 2021 Financial Results"
10/21/2021 8-K Quarterly results
Docs: "NeuroMetrix Reports Q3 2021 Financial Results"
07/22/2021 8-K Quarterly results
Docs: "NeuroMetrix Reports Q2 2021 Financial Results"
01/28/2021 8-K Quarterly results
Docs: "NeuroMetrix Reports Q4 and Full Year 2020 Financial Results"
10/22/2020 8-K Quarterly results
Docs: "NeuroMetrix Reports Q3 2020 Financial Results"
07/23/2020 8-K Quarterly results
04/23/2020 8-K Quarterly results
Docs: "NeuroMetrix Reports Q1 2020 Financial Results"
01/27/2020 8-K Quarterly results
Docs: "NeuroMetrix Reports Q4 and Full Year 2019 Financial Results"
10/17/2019 8-K Quarterly results
Docs: "NeuroMetrix Reports Q3 2019 Financial Results"
07/18/2019 8-K Quarterly results
Docs: "NeuroMetrix Reports Q2 2019 Financial Results"
04/25/2019 8-K Quarterly results
Docs: "NeuroMetrix Reports Q1 2019 Financial Results"
01/24/2019 8-K Quarterly results
Docs: "NeuroMetrix Reports Q4 and Full Year 2018 Financial Results"
10/17/2018 8-K Quarterly results
07/19/2018 8-K Quarterly results
Docs: "NeuroMetrix Reports Q2 2018 Financial Results Initial $3.8M Milestone Achieved under GSK Strategic Collaboration"
04/19/2018 8-K Quarterly results
Docs: "NeuroMetrix Reports Q1 2018 Financial Results GlaxoSmithKline Collaboration is Quarter Highlight"
01/25/2018 8-K Quarterly results
Docs: "NeuroMetrix Reports Q4 and Full Year 2017 Financial Results Q4 revenue $4.9M up 33%. Full year 2017 revenue $17.1M up 42%."
07/20/2017 8-K Form 8-K - Current report:
04/20/2017 8-K Form 8-K - Current report
01/26/2017 8-K Form 8-K - Current report
07/21/2016 8-K Quarterly results
Docs: "NeuroMetrix Reports Q2 2016 Financial Results and Highlights"
10/23/2013 8-K Quarterly results
Docs: "NeuroMetrix Reports Q3 2013 Results Progress in Building Broad Distribution Channel for SENSUS™ Pain Management System WALTHAM, Mass., October 23, 2013 -- NeuroMetrix, Inc. , a medical device company focused on the treatment and management of the neurological complications of diabetes, today reported business and financial highlights for the third quarter ended September 30, 2013. The Company is building a broad national distributional channel for its SENSUS Pain Management System, which is a novel transcutaneous electrical nerve stimulator intended for treating chronic pain. SENSUS is a convenient and wearable non-invasive device that offers physicians and their patients a non-narcotic pain relief option as a complement to medications. The device is lightweight and can be worn durin..."
04/25/2013 8-K Quarterly results
Docs: "NeuroMetrix Reports Q1 2013 Results"
02/19/2013 8-K Quarterly results
Docs: "NeuroMetrix Reports Q4 2012 Results"
10/25/2012 8-K Quarterly results
Docs: "NeuroMetrix Reports Q3 2012 Results Commercial and Regulatory Progress in Diabetes Portfolio"
07/26/2012 8-K Form 8-K - Current report
04/24/2012 8-K Quarterly results
Docs: "NeuroMetrix Reports Q1 2012 Results Operational and Strategic Progress in Diabetes Business"
02/15/2012 8-K Quarterly results
Docs: "NeuroMetrix Reports Q4 2011 Results Closes $8.5 Million Public Offering of Common Stock and Warrants"
10/27/2011 8-K Form 8-K - Current report
07/28/2011 8-K Form 8-K - Current report
04/28/2011 8-K Form 8-K - Current report
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy